Cancer Cell Membrane-Camouflaged Nanorods with Endoplasmic Reticulum Targeting for Improved Antitumor Therapy
Author:
Affiliation:
1. School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China
2. Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
3. University of Chinese Academy of Sciences, Beijing 100049, China
Funder
Natural Science Foundation of Liaoning Province
National Natural Science Foundation of China
Publisher
American Chemical Society (ACS)
Subject
General Materials Science
Link
https://pubs.acs.org/doi/pdf/10.1021/acsami.9b18388
Reference65 articles.
1. Nanocarriers as an emerging platform for cancer therapy
2. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
3. Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer
4. Improving drug delivery to solid tumors: Priming the tumor microenvironment
5. Progress and challenges towards targeted delivery of cancer therapeutics
Cited by 76 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Robust aptamer-targeted CRISPR/Cas9 delivery using mesenchymal stem cell membrane –liposome hybrid: BIRC5 gene knockout against melanoma;Nanomedicine: Nanotechnology, Biology and Medicine;2024-11
2. A one-dimensional bacterial cellulose nano-whiskers-based binary-drug delivery system for the cancer treatment;International Journal of Biological Macromolecules;2024-11
3. Selective delivery of imaging probes and therapeutics to the endoplasmic reticulum or Golgi apparatus: Current strategies and beyond;Advanced Drug Delivery Reviews;2024-09
4. PAFerroptosis Combined with Metabolic Disturbance of Mito by p52‐ZER6 for Enhanced Cancer Immunotherapy induced by Nano‐Bacilliform‐Enzyme;Advanced Healthcare Materials;2024-08-22
5. A Pyroptosis‐Inducing Arsenic(III) Nanomicelle Platform for Synergistic Cancer Immunotherapy;Advanced Healthcare Materials;2024-08-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3